Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Argonaute 2 stabilization of microRNAs controls adult neurogenesis and oligodendrogenesis.

Neural regeneration research·2026

Same author

Ouabain - a double-edged sword in tumor development and progression? a review of half a century.

Frontiers in physiology·2025

Same author

Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.

Neuro-oncology·2025

Same author

Targeting the Cargo Receptor TMED9 as a Therapeutic Strategy Against Brain Tumors.

Cells·2025

Same author

Monitoring ODC activity and polyamines in Bachmann-Bupp syndrome patient biological samples.

Methods in enzymology·2025

Same author

Collection, preparation, and biobanking of clinical specimens for analysis in polyaminopathies.

Methods in enzymology·2025

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and

Christopher K Yunker¹, William Golembieski, Nancy Lemke

¹Barbara Jane Levy Laboratory of Molecular Neuro-Oncology, Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202, USA.

International Journal of Cancer

|March 20, 2008

Summary

This summary is machine-generated.

Secreted acidic rich protein (SPARC) upregulates glioma matrix and suppresses tumor vascularity by decreasing VEGF. Understanding SPARC

More Related Videos

Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells

Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells

Published on: September 18, 2019

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

Related Experiment Videos

Last Updated: Jul 6, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells

Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells

Published on: September 18, 2019

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

Area of Science:

Oncology
Molecular Biology
Biochemistry

Background:

Glioblastomas are complex tumors with varied characteristics.
Secreted acidic rich protein (SPARC) is upregulated in gliomas and affects invasion and proliferation.
SPARC's role in matrix production and angiogenesis in other cancers suggests a similar mechanism in gliomas.

Purpose of the Study:

To investigate if SPARC-induced decrease in glioma growth is due to matrix alterations and/or reduced vascularity.
To assess the interaction between SPARC and Vascular Endothelial Growth Factor (VEGF) in gliomas.

Main Methods:

Analysis of SPARC's effect on glioma matrix composition, specifically collagen I.
Assessment of SPARC's impact on glioma vascularity.
Examination of SPARC's influence on VEGF expression and secretion, including VEGF165 transcript levels.

Main Results:

SPARC upregulates glioma matrix, promoting collagen fibrillogenesis.
SPARC suppresses glioma vascularity by decreasing VEGF expression and secretion.
Reduced VEGF165 transcript abundance contributes to SPARC-mediated VEGF suppression.

Conclusions:

SPARC modulates glioma growth by altering the tumor microenvironment and suppressing vascularity via reduced VEGF.
SPARC regulates VEGF function by limiting growth factor availability.
Targeting SPARC for glioma treatment requires careful consideration due to potential adverse effects on tumor vascularity and proliferation.